Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
5.12
+0.31 (6.44%)
At close: Mar 10, 2026, 4:00 PM EDT
5.25
+0.13 (2.54%)
After-hours: Mar 10, 2026, 7:45 PM EDT
Myriad Genetics Employees
Myriad Genetics had 2,700 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
2,700
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$305,370
Profits / Employee
-$135,519
Market Cap
478.76M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,700 | 0 | - |
| Dec 31, 2024 | 2,700 | 0 | - |
| Dec 31, 2023 | 2,700 | 100 | 3.85% |
| Dec 31, 2022 | 2,600 | 200 | 8.33% |
| Dec 31, 2021 | 2,400 | -300 | -11.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| NeoGenomics | 2,500 |
| OPKO Health | 2,275 |
| Fulgent Genetics | 1,315 |
| Castle Biosciences | 883 |
| CareDx | 765 |
| Burning Rock Biotech | 674 |
| Biodesix | 334 |
| MDxHealth | 312 |
MYGN News
- 14 days ago - Myriad Genetics Beats Q4 Expectations, Shares Surge Amid Core Franchise Growth - Seeking Alpha
- 15 days ago - Myriad Genetics, Inc. (MYGN) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Myriad Genetics Reports Fourth Quarter and Full-Year 2025 Financial Results; Reiterates 2026 Financial Guidance Reflecting Strengthened Execution - GlobeNewsWire
- 19 days ago - FirstGene Study Demonstrates High Analytical Sensitivity and Specificity for Each Component of the Test - GlobeNewsWire
- 22 days ago - Myriad Genetics to Release Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026 - GlobeNewsWire
- 7 weeks ago - Myriad Genetics, Inc. (MYGN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2025 Financial Results and Introduces Full Year 2026 Financial Guidance - GlobeNewsWire
- 2 months ago - Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire